7RQ Stock Overview
Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Neighbourly Pharmacy Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$12.30 |
| 52 Week High | CA$13.30 |
| 52 Week Low | CA$8.30 |
| Beta | 0.29 |
| 1 Month Change | -1.60% |
| 3 Month Change | 9.82% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -6.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7RQ | DE Consumer Retailing | DE Market | |
|---|---|---|---|
| 7D | 0% | -6.5% | -3.1% |
| 1Y | n/a | -37.2% | -0.5% |
Return vs Industry: Insufficient data to determine how 7RQ performed against the German Consumer Retailing industry.
Return vs Market: Insufficient data to determine how 7RQ performed against the German Market.
Price Volatility
| 7RQ volatility | |
|---|---|
| 7RQ Average Weekly Movement | 4.9% |
| Consumer Retailing Industry Average Movement | 6.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 7RQ has not had significant price volatility in the past 3 months.
Volatility Over Time: 7RQ's weekly volatility has decreased from 11% to 5% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 3,648 | Skip Bourdo | neighbourlypharmacy.ca |
Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy’s RX, and Drug Trading.
Neighbourly Pharmacy Inc. Fundamentals Summary
| 7RQ fundamental statistics | |
|---|---|
| Market cap | €569.35m |
| Earnings (TTM) | -€22.20m |
| Revenue (TTM) | €593.81m |
1.0x
P/S Ratio-25.6x
P/E RatioIs 7RQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7RQ income statement (TTM) | |
|---|---|
| Revenue | CA$874.61m |
| Cost of Revenue | CA$527.56m |
| Gross Profit | CA$347.05m |
| Other Expenses | CA$379.76m |
| Earnings | -CA$32.70m |
Last Reported Earnings
Dec 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.72 |
| Gross Margin | 39.68% |
| Net Profit Margin | -3.74% |
| Debt/Equity Ratio | 44.5% |
How did 7RQ perform over the long term?
See historical performance and comparison